2025-19565Notice

FDA Greenlights Double Labels to Fight Screwworm in Livestock

Published Date: 10/16/2025

Notice

Summary

The FDA just released new guidance letting animal drug makers put two labels on one product—one fully approved and one conditionally approved—to fight the pesky New World screwworm. This helps companies update their products faster without extra costs or delays. If you make or sell animal drugs, this change means smoother labeling and quicker protection for animals starting now.

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

FDA Allows Dual Drug Labeling

On October 16, 2025 the FDA issued final Guidance for Industry #299 that says a single new animal drug product label may include both an intended use fully approved under section 512(b) of the FD&C Act and an intended use conditionally approved under section 571 for treating or preventing New World screwworm (Cochliomyia hominivorax). This 'dual labeling' guidance applies specifically when the added claim is for New World screwworm myiasis.

Guidance Effective Immediately for NWS

The FDA issued this guidance immediately effective on October 16, 2025 so the Agency can act expeditiously to review and, where appropriate, approve or authorize animal drugs for New World screwworm (NWS) myiasis; FDA said it is issuing the guidance now because NWS has progressed north since 2022 and is approaching the U.S. border with Mexico and poses an emerging threat to livestock, pets, wildlife, and food security.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
10/16/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in